Merck KGaA acquires BGIP

DARMSTADT, Germany Drug maker Merck KGaA has acquired an Indian bioscience company based in the city of Bangalore, Merck announced Tuesday.

The German drug maker – a separate company from U.S.-based Merck & Co. – announced the acquisition of Bangalore Genei (India) Private, having purchased it from Sanmar Group through its Indian subsidiary, Merck Specialties Private.

Merck said the acquisition would make it one of the leading bioscience companies in India, though it did not disclose financial terms of the deal. BGIP develops proteonomic and genomic research products, having generated $4.45 million in revenues during the 2008-2009 fiscal year.